Approaches to Characterize Biased Agonists in Early Phase Drug Development
Time: 2:45 pm
day: Day Two
Details:
- Reviewing the literature and rationale behind bias signaling in GPCR research and development
- Detailing methods used to illuminate bias in downstream pathways
- Linking signaling bias to different physiological outcomes
